ExoticRx · exoticrx.com/drugs/ilunocitinib
Ilunocitinib
Greylan
Drug Class
Routes
Indications
Mechanism of Action
Selective Janus kinase 1 (JAK1) inhibitor that blocks cytokine signaling pathways involved in pruritus and inflammation, reducing itch and allergic skin inflammation in dogs.
Side effects & warnings
New veterinary JAK inhibitor with limited post-market data. Monitor CBC and liver values. May increase susceptibility to infections. Similar class warnings to oclacitinib.
Species with Ilunocitinib dosing data (1 dose rule)
Evidence levels across 1 dose rule
Each ExoticRx dose rule is graded by the strength of its primary evidence — see the editorial process.
Backed by a published primary source
- · FDA conditional approval data; FDA openFDA Adverse Event Database
Sample dosing (1 of 1 cited rule)
Free-tier preview — dog and cat dosing. Pro and Student unlock all 1 species including reptiles, birds, pocket pets, livestock, and equine.
| Species | Route | Dose | Frequency | Evidence | Source |
|---|---|---|---|---|---|
| Dog (Domestic) | PO | 0.6–1.8 mg/kg | q24h | Moderate | FDA conditional approval data; FDA openFDA Adverse Event Database |
Upgrade for Full Details
Upgrade to Pro or Student to access full drug details including mechanism of action, warnings, dose ranges, and frequency.
View PlansMore Immunosuppressant drugs
Source citations and evidence levels available on the live page. Reference only — verify against current literature before clinical use.